Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Prospective Identification of Tumorigenic Prostate Cancer Stem Cells

Anne T. Collins, Paul A. Berry, Catherine Hyde et al. · Cancer Research · 2005 · 2.8K citations

Medicine, Cell Biology, Oncology +17

The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations

Anna Dubrovska, Sungeun Kim, Richard J. Salamone et al. · Proceedings of the National Academy of Sciences · 2008 · 563 citations · Full text

Medicine, Cell Biology, Oncology +17

Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor

Sauveur-Michel Maira, Sabina Pecchi, Alan Huang et al. · Molecular Cancer Therapeutics · 2011 · 529 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing

Tomoki Todo, Robert L. Martuza, Samuel D. Rabkin et al. · Proceedings of the National Academy of Sciences · 2001 · 462 citations · Full text

Life Sciences, Immunology, Oncology +17